These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16496247)

  • 21. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraocular pressure and progression in exfoliative eyes with ocular hypertension or glaucoma.
    Harju M
    Acta Ophthalmol Scand; 2000 Dec; 78(6):699-702. PubMed ID: 11167237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular pressure changes over 21 years - a longitudinal age-cohort study in northern Sweden.
    Åström S; Stenlund H; Lindén C
    Acta Ophthalmol; 2014 Aug; 92(5):417-20. PubMed ID: 23902137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does cataract surgery reduce the long-term risk of glaucoma in eyes with pseudoexfoliation syndrome?
    Kristianslund O; Østern AE; Råen M; Sandvik GF; Drolsum L
    Acta Ophthalmol; 2016 May; 94(3):261-5. PubMed ID: 26749122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of different glaucomas seen at a tertiary center: A 10-year overview.
    Sihota R; Midha N; Selvan H; Sidhu T; Swamy DR; Sharma A; Gupta A; Gupta V; Dada T; Chaudhary S
    Indian J Ophthalmol; 2017 Feb; 65(2):128-132. PubMed ID: 28345568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series.
    Bleisch D; Furrer S; Funk J
    BMC Ophthalmol; 2015 Dec; 15():179. PubMed ID: 26667206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transvitreal endocyclophotocoagulation.
    Haller JA
    Trans Am Ophthalmol Soc; 1996; 94():589-676. PubMed ID: 8981713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in visual acuity and refraction in the exfoliation syndrome. A five-year follow-up study.
    Puska PM; Tarkkanen AH
    Eur J Ophthalmol; 2001; 11(3):245-51. PubMed ID: 11681503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
    Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
    Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraocular pressure in exfoliation syndrome.
    Klemetti A
    Acta Ophthalmol Suppl (1985); 1988; 184():54-8. PubMed ID: 2853921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for visual field progression in newly diagnosed exfoliation glaucoma patients in Sweden.
    Ayala M
    Sci Rep; 2022 Jun; 12(1):10763. PubMed ID: 35750795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
    Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of open-angle glaucoma in central Sweden.
    Ekström C
    Acta Ophthalmol; 2008 Nov; 86(7):747-54. PubMed ID: 18785965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
    Konstas AG; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
    Eye (Lond); 2004 Sep; 18(9):893-9. PubMed ID: 15002024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified goniotomy as an alternative to trabectome in primary open angle glaucoma and pseudoexfoliation glaucoma: 1 year results.
    Pahlitzsch M; Gonnermann J; Maier AB; Bertelmann E; Klamann MK; Erb C
    Can J Ophthalmol; 2017 Feb; 52(1):92-98. PubMed ID: 28237157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of phacoemulsification on intraocular pressure in eyes with primary angle closure glaucoma after trabeculectomy].
    Yang WH; Han Q; Chen S; Yan H
    Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):104-9. PubMed ID: 26906705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diode laser cyclophotocoagulation paves way to a safer trabeculectomy in eyes with medically uncontrollable intraocular pressure.
    Singh K; Dangda S; Ahir N; Mutreja A; Bhattacharyya M
    Int Ophthalmol; 2017 Apr; 37(2):365-370. PubMed ID: 27287344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma.
    Elgin U; Sen E; Çolak S; Yılmazbas P
    Int Ophthalmol; 2019 Jun; 39(6):1211-1217. PubMed ID: 29696466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.